JP2013520448A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013520448A5 JP2013520448A5 JP2012554168A JP2012554168A JP2013520448A5 JP 2013520448 A5 JP2013520448 A5 JP 2013520448A5 JP 2012554168 A JP2012554168 A JP 2012554168A JP 2012554168 A JP2012554168 A JP 2012554168A JP 2013520448 A5 JP2013520448 A5 JP 2013520448A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogen
- composition
- agent
- subject
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002163 immunogen Effects 0.000 claims 32
- 210000001519 tissue Anatomy 0.000 claims 17
- 239000003795 chemical substances by application Substances 0.000 claims 16
- 239000003814 drug Substances 0.000 claims 14
- 241000605862 Porphyromonas gingivalis Species 0.000 claims 13
- -1 immunogen Substances 0.000 claims 11
- 229940079593 drug Drugs 0.000 claims 10
- 239000003242 anti bacterial agent Substances 0.000 claims 6
- 239000002260 anti-inflammatory agent Substances 0.000 claims 6
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- 206010061218 Inflammation Diseases 0.000 claims 5
- 230000028993 immune response Effects 0.000 claims 5
- 230000004054 inflammatory process Effects 0.000 claims 5
- 244000005700 microbiome Species 0.000 claims 5
- 102000037865 fusion proteins Human genes 0.000 claims 4
- 108020001507 fusion proteins Proteins 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 238000001804 debridement Methods 0.000 claims 2
- 238000009499 grossing Methods 0.000 claims 2
- NVEPPWDVLBMNMB-SNAWJCMRSA-N 1-methyl-2-[(e)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound CN1CCCN=C1\C=C\C1=C(C)C=CS1 NVEPPWDVLBMNMB-SNAWJCMRSA-N 0.000 claims 1
- 208000006558 Dental Calculus Diseases 0.000 claims 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 claims 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 claims 1
- 230000005875 antibody response Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229960005121 morantel Drugs 0.000 claims 1
- 210000002200 mouth mucosa Anatomy 0.000 claims 1
- VRYKTHBAWRESFI-VOTSOKGWSA-N oxantel Chemical group CN1CCCN=C1\C=C\C1=CC=CC(O)=C1 VRYKTHBAWRESFI-VOTSOKGWSA-N 0.000 claims 1
- 229960000535 oxantel Drugs 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims 1
- 229960004546 thiabendazole Drugs 0.000 claims 1
- 235000010296 thiabendazole Nutrition 0.000 claims 1
- 239000004308 thiabendazole Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010900846A AU2010900846A0 (en) | 2010-02-26 | Treatment or prevention of infection | |
| AU2010900846 | 2010-02-26 | ||
| PCT/AU2011/000206 WO2011103633A1 (en) | 2010-02-26 | 2011-02-25 | Treatment or prevention of infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013520448A JP2013520448A (ja) | 2013-06-06 |
| JP2013520448A5 true JP2013520448A5 (OSRAM) | 2014-04-10 |
| JP5977677B2 JP5977677B2 (ja) | 2016-08-24 |
Family
ID=44506081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012554168A Active JP5977677B2 (ja) | 2010-02-26 | 2011-02-25 | 感染の処置又は防止 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9125853B2 (OSRAM) |
| EP (2) | EP3260135A1 (OSRAM) |
| JP (1) | JP5977677B2 (OSRAM) |
| KR (2) | KR20130036185A (OSRAM) |
| CN (2) | CN104689308B (OSRAM) |
| AU (1) | AU2011220335B2 (OSRAM) |
| BR (1) | BR112012021383A2 (OSRAM) |
| CA (1) | CA2790219C (OSRAM) |
| HK (1) | HK1248535A1 (OSRAM) |
| MX (1) | MX342832B (OSRAM) |
| MY (1) | MY162557A (OSRAM) |
| NZ (1) | NZ601890A (OSRAM) |
| RU (1) | RU2617399C2 (OSRAM) |
| SG (2) | SG183376A1 (OSRAM) |
| TW (1) | TWI583392B (OSRAM) |
| WO (1) | WO2011103633A1 (OSRAM) |
| ZA (1) | ZA201206204B (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811530B1 (pt) | 2007-05-14 | 2019-01-02 | Research Foundation Of State Univ Of New York | composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície |
| WO2010022463A1 (en) * | 2008-08-29 | 2010-03-04 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of p.gingivalis infection |
| US20110104179A1 (en) * | 2009-06-19 | 2011-05-05 | Oral Health Australia Pty Ltd | Protease inhibitory peptides |
| US20170247674A1 (en) * | 2014-10-14 | 2017-08-31 | The Forsyth Institute | Conjugates for delivery to mitochondria |
| KR101587113B1 (ko) * | 2014-10-29 | 2016-01-20 | 경북대학교 산학협력단 | 치주염 유발 장알균(Enterococcus faecalis)을 특이적으로 사멸시키는 신규한 박테리오파지 |
| EP3389704B1 (en) * | 2015-12-15 | 2022-01-26 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Vaccination against diabetes, obesity and complications thereof |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210035A (en) | 1980-05-19 | 1993-05-11 | Board Of Trustees Of Leland Stanford Jr. University | Non-reventing live vaccines |
| US4837151A (en) | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
| US4735801A (en) | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| WO1993014779A1 (en) | 1992-01-30 | 1993-08-05 | Corvas International, Inc. | Trypsin inhibitors |
| JPH0797395A (ja) | 1993-09-28 | 1995-04-11 | Kyowa Medex Co Ltd | ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途 |
| AUPN627595A0 (en) | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| AUPO652897A0 (en) | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
| AUPP893999A0 (en) | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| AUPQ485999A0 (en) | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US8283135B2 (en) * | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| GB0114185D0 (en) | 2001-06-12 | 2001-08-01 | Protherics Molecular Design Lt | Compounds |
| GB2370838A (en) | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex |
| US20060142203A1 (en) | 2002-06-26 | 2006-06-29 | Todd Hembrough | Compositions and methods comprising protein activated receptor antagonists |
| US20070036734A1 (en) | 2003-03-17 | 2007-02-15 | Kirin Beer Kabushiki Kaisha | Therapeutic agent for periodontal disease |
| US20050070543A1 (en) * | 2003-07-11 | 2005-03-31 | Pharmacia Corporation | Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ACE inhibitor for the treatment of central nervous system damage |
| DE602004031024D1 (de) | 2003-08-15 | 2011-02-24 | Univ Florida | Die identifikation von polynukleotiden von porphyromonas gingivalis-virulenz zur diagnose, behandlung und beobachtung von periodontalerkrankungen |
| GB0411150D0 (en) * | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| JP2008510726A (ja) | 2004-08-20 | 2008-04-10 | エントレメッド インコーポレイテッド | プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法 |
| NZ554331A (en) | 2004-09-23 | 2009-04-30 | Univ Melbourne | Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| US7888482B2 (en) | 2006-02-10 | 2011-02-15 | Amgen Inc. | Antibodies that bind PAR-2 |
| JP2009544279A (ja) | 2006-06-27 | 2009-12-17 | オーラル ヘルス オーストラリア ピーティーワイ リミテッド | 歯周病の予防に有用なポルフィロモナス・ジンジバリスポリペプチド |
| ES2432690T3 (es) | 2007-07-12 | 2013-12-04 | Oral Health Australia Pty Ltd | Tratamiento de biopelícula |
| RU2366378C1 (ru) * | 2008-04-07 | 2009-09-10 | Сергей Владимирович Сирак | Способ костной пластики при непосредственной дентальной имплантации |
| US9366673B2 (en) * | 2009-08-02 | 2016-06-14 | Sanofi Pasteur Limited | Porphyromonas gingivalis polypeptides |
-
2011
- 2011-02-23 MY MYPI2012003796A patent/MY162557A/en unknown
- 2011-02-25 SG SG2012061099A patent/SG183376A1/en unknown
- 2011-02-25 EP EP17167876.6A patent/EP3260135A1/en not_active Withdrawn
- 2011-02-25 AU AU2011220335A patent/AU2011220335B2/en active Active
- 2011-02-25 TW TW100106637A patent/TWI583392B/zh not_active IP Right Cessation
- 2011-02-25 MX MX2012009730A patent/MX342832B/es active IP Right Grant
- 2011-02-25 JP JP2012554168A patent/JP5977677B2/ja active Active
- 2011-02-25 CN CN201510084917.9A patent/CN104689308B/zh active Active
- 2011-02-25 CA CA2790219A patent/CA2790219C/en active Active
- 2011-02-25 BR BR112012021383A patent/BR112012021383A2/pt not_active Application Discontinuation
- 2011-02-25 SG SG10201500976XA patent/SG10201500976XA/en unknown
- 2011-02-25 NZ NZ601890A patent/NZ601890A/en not_active IP Right Cessation
- 2011-02-25 WO PCT/AU2011/000206 patent/WO2011103633A1/en not_active Ceased
- 2011-02-25 EP EP11746760.5A patent/EP2538970A4/en not_active Withdrawn
- 2011-02-25 CN CN2011800183736A patent/CN102883744A/zh active Pending
- 2011-02-25 RU RU2012136724A patent/RU2617399C2/ru not_active IP Right Cessation
- 2011-02-25 KR KR1020127022892A patent/KR20130036185A/ko not_active Ceased
- 2011-02-25 KR KR1020177026249A patent/KR20170109685A/ko not_active Ceased
- 2011-02-25 US US13/580,090 patent/US9125853B2/en active Active
-
2012
- 2012-08-17 ZA ZA2012/06204A patent/ZA201206204B/en unknown
-
2018
- 2018-06-26 HK HK18108159.0A patent/HK1248535A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240350635A1 (en) | Hypertonic antimicrobial therapeutic compositions | |
| ES2705244T3 (es) | Levocetirizina y montelukast para el tratamiento de la gripe y del resfriado común | |
| JP2013520448A5 (OSRAM) | ||
| AU2019100465B4 (en) | Treatment and prevention of the common cold using povidone-iodine | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| JP2013541583A5 (OSRAM) | ||
| PL2043637T3 (pl) | Sposoby i leki do podawania ibuprofenu | |
| JP2016525548A5 (OSRAM) | ||
| RU2012136724A (ru) | Лечение или профилактика инфекции | |
| CL2024003601A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2013523628A5 (OSRAM) | ||
| Karunakar et al. | Comparative evaluation of efficacy of diclofenac and ketoprofen administered using transdermal drug delivery route in management of post endodontic pain: A randomized controlled clinical trial | |
| JP2015515974A5 (OSRAM) | ||
| US20060251704A1 (en) | Methods and devices for efficacious treatment of aphthous ulcers | |
| ES2678122T3 (es) | Comprimidos bucales mucoadherentes para el tratamiento del herpes orofacial | |
| RU2019102890A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| RU2023125283A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| RU2010129491A (ru) | Способ лечения и профилактики кариеса зубов | |
| HK1249851B (en) | Treatment and prevention of the common cold using povidone-iodine | |
| BRPI0900639C1 (pt) | composição farmacêutica e uso desta para tratamento e/ou prevenção de doenças do trato respiratório | |
| Mahajan et al. | Medical Mycology Case Reports | |
| Chongcharoen | Effectiveness of different interdental brushes to cleaning the interproximal areas | |
| AR082646A1 (es) | Composiciones y metodos para tratar sindrome mielodisplasico | |
| UA100554U (uk) | Спосіб місцевого лікування важких клінічних форм червоного плескатого лишаю слизової оболонки порожнини рота |